Digestive Disease Models

Creative Bioarray is a preclinical Contract Research Organization (CRO) that specializes in efficacy studies. Our area of expertise lies in developing a wide range of models of digestive disease, and with years of experience in this field, we offer in vivo pharmacology studies that provide you with specialized answers about the potential efficacy of your compounds. According to your needs, we can perform classical, Intravenous (IV), Intraperitoneal (IP) or Intrarectal administration. Our team of experts employs innovative techniques to conduct these studies, ensuring that you receive reliable and accurate results. With our services, you can rest assured that your compounds will be thoroughly tested and evaluated, giving you the confidence you need to take your research to the next level.

The digestive tract, commonly referred to as the gastrointestinal (GI) tract or system, encompasses various organs such as the stomach, large and small intestines, liver, pancreas, and gallbladder. Digestive ailments can significantly impact this intricate system, often manifesting in symptoms like heartburn, nausea, vomiting, abdominal pain, constipation, or diarrhea. To gain a deeper understanding of these conditions and their underlying mechanisms, Digestive Disease Animal Models play a crucial role. These models allow researchers to replicate human digestive disorders in animals, providing a controlled environment to study the progression of diseases, evaluate potential treatments, and assess the efficacy of novel therapies. By leveraging these models, we can gain insights into the pathophysiology of digestive diseases, leading to more effective and targeted therapeutic strategies for patients.

Fig. 1 Digestive system

Our Digestive Disease Models

When it comes to developing drugs for digestive diseases, researchers often face the challenge of avoiding harm to patients during the drug development process. In order to overcome this challenge, animal disease models are used instead. At Creative Bioarray, we provide a number of validated models of digestive disease. Each disease type has multiple methods to create models that provide different disease parameters for your candidate compounds.

Fig. 2 Workflow of our digestive disease model

Quotation and Ordering

Creative Bioarray offers preclinical services that are both cost-effective and time-efficient, adhering to the highest standards of quality and precision. A dedicated team of scientists will be assigned to guide you in selecting the most appropriate model and developing study-specific protocols, ensuring optimal results with minimal resource expenditure. If you are interested in our services, please feel free to contact us at any time or submit an inquiry directly.

Reference

Thomas Abraham J V, et al. A Deep-Learning Approach for Identifying and Classifying Digestive Diseases. Symmetry, 2023, 15(2): 379.

For research use only. Not for any other purpose.